The FDA has issued a CRL to Replimmune regarding the BLA for vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.

The prevalence of frailty was 33% among a US-wide cohort of patients with RMDs, with the highest rates found among those with fibromyalgia or CTDs.

Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.

The HHS is directing the Organ Procurement and Transplantation Network to implement new safety measures following accusations of negligence.

A total of 4 new recommendations are included as part of the American Academy of Dermatology’s atopic dermatitis guideline updates.

Tumor necrosis factor inhibitor use in patients with IMIDs did not increase the risk of de novo heart failure or worsen existing heart failure.

While most cases of bug bites can be managed at home, some symptoms are more serious and should prompt patients to seek ...

Early intervention with IL-17 inhibitors among patients with plaque psoriasis is associated with improved relapse and remission rates.

An updated human papillomavirus-positive oropharyngeal carcinoma staging classification improves prognostication and management.

Last Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, including the National Institutes of Health (NIH), U.S. Food and Drug ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

More children received the DTP vaccine in 2024 than 2023, but more than 14 million infants remain unvaccinated.